KCNQ2 potassium channel openers (BMS)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameKCNQ2 potassium channel openers (BMS)
Drug Alias Namecinnamide derivatives (BMS)cinnamamides (BMS)compound 2 (BMS)compound 1 (BMS)BMS-568274 +[7] 
ClassificationSmall molecules
Mechanisms of ActionKCNQ (Kv7) potassium channel agonistsNeuroprotectants
TargetsKCNQ (Kv7) potassium channel
Therapy Area/IndicationsNeuralgiaMigraine DisordersEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsNeuralgiaMigraine DisordersEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A